HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metalloendoprotease cleavage triggers gelsolin amyloidogenesis.

Abstract
Amyloid diseases like Alzheimer's disease and familial amyloidosis of Finnish type (FAF) stem from endoproteolytic cleavage of a precursor protein to generate amyloidogenic peptides that accumulate as amyloid deposits in a tissue-specific manner. FAF patients deposit both 8 and 5 kDa peptides derived from mutant (D187Y/N) plasma gelsolin in the extracellular matrix (ECM). The first of two aberrant sequential proteolytic events is executed by furin to yield a 68 kDa (C68) secreted fragment. We now identify the metalloprotease MT1-matrix metalloprotease (MMP), an integral membrane protein active in the ECM, as a protease that processes C68 to the amyloidogenic peptides. We further demonstrate that ECM components are capable of accelerating gelsolin amyloidogenesis. Proteolysis by MT1-MMP-like proteases proximal to the unique chemical environment of the ECM offers an explanation for the tissue-specific deposition observed in FAF and provides critical insight into new therapeutic strategies.
AuthorsLesley J Page, Ji Young Suk, Mary E Huff, Hee-Jong Lim, John Venable, John Yates, Jeffery W Kelly, William E Balch
JournalThe EMBO journal (EMBO J) Vol. 24 Issue 23 Pg. 4124-32 (Dec 07 2005) ISSN: 0261-4189 [Print] England
PMID16281052 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid
  • Gelsolin
  • Mmp14 protein, mouse
  • Peptide Fragments
  • Matrix Metalloproteinases, Membrane-Associated
  • Metalloendopeptidases
  • Matrix Metalloproteinase 14
Topics
  • Amyloid (biosynthesis)
  • Animals
  • Cell Line
  • Cell Line, Tumor
  • Extracellular Matrix (physiology)
  • Gelsolin (metabolism)
  • Humans
  • Hydrolysis
  • Matrix Metalloproteinase 14
  • Matrix Metalloproteinases, Membrane-Associated
  • Metalloendopeptidases (physiology)
  • Mice
  • Peptide Fragments (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: